Effects of HIV & HAART on Sleep & Daytime Function

艾滋病毒的影响

• 批准号: 6876010
• 负责人: PHILIP L SMITH
• 金额: $ 60.81万
• 依托单位: JOHNS HOPKINS UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-09-30 至 2008-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6876010
• 关键词: AIDS therapy; HIV envelope protein gp120; HIV infections; behavioral /social science research tag; cellular immunity; clinical research; disease /disorder proneness /risk; fatigue; functional ability; genetically modified animals; human subject; humoral immunity; hypoxia; interleukin 1; laboratory mouse; leptin; male; neuropsychology; obesity; patient oriented research; protease inhibitor; quality of life; respiratory airflow disorder; sleep apnea; sleep disorders; tumor necrosis factor alpha

DESCRIPTION (provided by applicant): HIV is recognized as a devastating infection that leads to severe morbidity and earlier death. It is known that HIV infection is associated not only with disruptions in immune function but also in sleep with daytime fatigue, somnolence and impaired quality of life. Highly Active Anti-Retroviral Therapy (HAART) is now extending the life expectancy of those infected with HIV either allowing or producing chronic medical conditions and significant associated medical comorbidity. Our preliminary data indicate that both HIV infection and HAART are associated with substantial daytime fatigue. Moreover, HAART is also associated with sleep apnea, a known cause of sleep disruption and daytime somnolence. Our major hypothesis is that HIV infection, HAART, and associated alterations in humoral factors and cellular immunity lead to sleep disruption and sleep apnea, which both cause daytime dysfunction. In Specific Aim 1, we will elucidate the effects of HIV and HAART on nocturnal sleep architecture and daytime function. We hypothesize that HIV infection will be associated with sleep disruption and alterations in measures of daytime sleepiness, neurocognitive and neurobehavioral function, and quality of life. In Specific Aim 2, we will delineate the effects of HIV and HAART on the severity of upper airway obstruction and sleep. We hypothesize that HAART, but not HIV infection, is associated with an increased susceptibility for sleep apnea due to alterations in regional fat distribution and leptin. In Specific Aim 3, we will elucidate specific humoral and molecular pathways involved in the pathogenesis of upper airway, ventilatory and sleep/wake dysregulation. In this proposal, we capitalize on the well-established Baltimore site or the Multicenter Aids Cohort Study (MACS), a longitudinal study of HIV infection in gay men, to determine the impact of these factors on sleep quality, sleep apnea and daytime function. In a series of complementary murine studies, we further probe causal pathways involved in the pathogenesis of upper airway, respiratory and sleep/wake dysfunction. Conventional methods will be employed to assess sleep architecture, cellular immunity, humoral factors and daytime function, while novel analytic approaches will be used to quantify effects of HIV infection and therapy on sleep structure and upper airway function.

描述（由申请人提供）： 艾滋病毒被认为是一种毁灭性的感染，导致严重的发病率和早期死亡。 众所周知，艾滋病毒感染不仅与免疫功能的干扰有关，而且与白天疲劳，脾气暴躁和生活质量受损有关。 高度活跃的抗逆转录病毒疗法（HAART）现在正在延长感染HIV的人的预期寿命，允许或产生慢性医疗状况以及显着相关的医疗合并症。 我们的初步数据表明，HIV感染和HAART都与白天疲劳相关。 此外，Haart还与睡眠呼吸暂停有关，这是已知的睡眠中断和白天的嗜睡原因。 我们的主要假设是，艾滋病毒感染，HAART和相关的体液因素和细胞免疫的改变会导致睡眠破坏和睡眠呼吸暂停，这两者都会引起白天功能障碍。 在特定的目标1中，我们将阐明HIV和HAART对夜间睡眠结构和白天功能的影响。 我们假设HIV感染将与睡眠中断和白天嗜睡，神经认知和神经行为功能以及生活质量的措施的改变有关。 在特定的目标2中，我们将描述HIV和HAART对上气道阻塞和睡眠严重程度的影响。 我们假设HAART（而不是HIV感染）由于区域脂肪分布和瘦素的改变而导致睡眠呼吸暂停的易感性增加。在特定的目标3中，我们将阐明参与上呼吸道发病机理，通风和睡眠/唤醒失调的特定体液和分子途径。 在该提案中，我们利用了良好的巴尔的摩站点或多中心艾滋病队列研究（MAC），这是对同性恋者HIV感染的纵向研究，以确定这些因素对睡眠质量，睡眠呼吸暂停和白天功能的影响。 在一系列互补的鼠研究中，我们进一步探测了涉及上呼吸道发病机理，呼吸道和睡眠/唤醒功能障碍的因果途径。 将采用常规方法来评估睡眠体系结构，细胞免疫，体液因素和白天功能，而新型的分析方法将用于量化HIV感染和治疗对睡眠结构和上空气道功能的影响。